专利号:US-2006264608-A1 优先权日:2001-08-03 标题 :Bi-directional synthesis of oligoguanidine transport agents 发明人:WENDER PAUL A; VANDEUSEN CHRISTOPHER L; PATTABIRAMAN KANAKA; PELKEY ERIN T; JESSOP THEODORE C 权利人:WENDER PAUL A; VANDEUSEN CHRISTOPHER L; PATTABIRAMAN KANAKA; PELKEY ERIN T; JESSOP THEODORE C 摘要:Synthesis routes that can be adapted to large scale synthesis of oligoguanidine compounds such as oligoarginine compounds are described which use a perguanidinylation step to convert a group of ω-amino groups to the corresponding guanidinyl groups. These compounds find utility as transport agents. Modified oligoguanidine compounds are also described.
专利号:US-7067698-B2 优先权日:2001-08-03 标 题 :Bi-directional synthesis of oligoguanidine transport agents 发明人:WENDER PAUL A; VANDEUSEN CHRISTOPHER L; PATTABIRAMAN KANAKA; PELKEY ERIN T; JESSOP THEODORE C 权利人:UNIV LELAND STANFORD JUNIOR 摘要:Synthesis routes that can be adapted to large scale synthesis of oligoguanidine compounds such as oligoarginine compounds are described which use a perguanidinylation step to convert a group of ω-amino groups to the corresponding guanidinyl groups. These compounds find utility as transport agents. Modified oligoguanidine compounds are also described.
专利号:US-2014073804-A1 优先权日:2011-02-24 标 题 :Process for the preparation of zanamivir 发明人:CHARAN GANPAT DAN SHIMBHU; TEHARE AJAY ONKARSINGH; SINGH KUMAR KEMLESH LAXMI 权利人:CHARAN GANPAT DAN SHIMBHU; TEHARE AJAY ONKARSINGH; SINGH KUMAR KEMLESH LAXMI 摘要:The present invention provides a process for preparing 5-(acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy-D-glycero-D-galacto-non-enonic acid Formula (I), which process comprises reducing compound of Formula (IV) by Lindlar catalyst in presence of hydrogen to obtain compound of Formula (V). reacting compound of Formula (V) with pyrazole-1H-carboxamidine or its suitable salt to obtain compound of Formula (VIII). hydrolyzing the compound of Formula (VIII) to give compound of Formula (I). The present invention also provides compounds of formula (VIII) which may be used in the synthesis of zanamivir. The present invention also provides process for preparing compound of formula (VIII) and process involving the use of Formula (VIII), including in the synthesis of zanamivir.
专利号:US-7834174-B2 优先权日:2004-09-10 标 题 :Per-6-guanidino-, alkylamino-cyclodextrins, methods of their synthesis and their use for the compaction of DNA and intercellular delivery 发明人:MAVRIDIS IRENE M; YANNAKOPOULOU KONSTANTINA; ELIADOU KYRIAKI; MOURTZIS NIKOLAOS; AGGELIDOU CHRYSI 权利人:MAVRIDIS IRENE M; YANNAKOPOULOU KONSTANTINA; ELIADOU KYRIAKI; MOURTZIS NIKOLAOS; AGGELIDOU CHRYSI 摘要:The invention relates to new compounds of type hexakis(6-deoxy-6-NH(CH 2 ) n —R 1 )α-cyclodextrin and heptakis(6-deoxy-6-NH(CH 2 ) n —R 1 )-(β-cyclodextrin, and octakis(6-deoxy-6-NH(CH 2 ) n —R 1 )-γ-cyclodextrin, where n=2-6 when R 1 =NH 2 and n=0 when R 1 =C(â•?NH)NH 2 and n=2-6 when R 1 =NH—C(â•?NH)NH 2 and their use in the compaction of DNA and in cell permeation. The invention also relates to methods of synthesis of the above compounds.
专利号:US-8178672-B2 优先权日:2004-10-19 标 题:Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 MAP kinase 发明人:ASHWELL MARK A; TANDON MANISH; LAPIERRE JEAN-MARC 权利人:ASHWELL MARK A; TANDON MANISH; LAPIERRE JEAN-MARC; ARQULE INC 摘要:An efficient route for the synthesis is of formula (I) of imidazooxazole and imidazothiazole inhibitors of the p38 MAP kinase pathway, useful as therapeutics for disease conditions including inflammation and auto-immune responses is described.
专利号:US-8653282-B2 优先权日:2007-10-18 标 题:Preparation of dihydrothieno [3,2-D] pyrimidines and intermediates used therein 发明人:FRUTOS ROGELIO; KRISHNAMURTHY DHILEEPKUMAR; MULDER JASON ALAN; RODRIGUEZ SONIA; SENANAYAKE CHRIS HUGH; TAMPONE THOMAS G 权利人:FRUTOS ROGELIO; KRISHNAMURTHY DHILEEPKUMAR; MULDER JASON ALAN; RODRIGUEZ SONIA; SENANAYAKE CHRIS HUGH; TAMPONE THOMAS G; BOEHRINGER INGELHEIM INT 摘要:The invention relates to improved methods of preparing dihydrothienopyrimidines of formula 1, and intermediates thereof, (I) wherein X is SO or SO 2 , preferably SO, and wherein R A , R 1 , R 2 , R 3 , R 4 and R 5 have the meanings given in the description. The methods according to this invention are more suitable for large-scale synthesis of said compounds than prior methods because the new synthetic process avoids distillation and chromatographic purification between steps and results in a higher overall yield of the desired product.
参考文献:10.1007/s12257-022-0222-6 摘要:Heo T, Hoang QT, Cao TGN, Oh S, Ryu M, Shim MS, Choi S. Guanidinium-functionalized Block Copolyelectrolyte Micelleplexes for Safe and Efficient siRNA Delivery. Biotechnol Bioproc E. 2022 Dec;27(6):1004–13. doi: 10.1007/s12257-022-0222-6. 参考文献:10.1124/mol.119.115964 摘要:Lee TD, Lee OW, Brimacombe KR, Chen L, Guha R, Lusvarghi S, Tebase BG, Klumpp-Thomas C, Robey RW, Ambudkar SV, Shen M, Gottesman MM, Hall MD. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Molecular Pharmacology. 2019 Nov;96(5):629–40. doi: 10.1124/mol.119.115964. 参考文献:10.1038/s41428-023-00787-4 摘要:Izawa H, Yagi A, Umemoto R, Ifuku S. Water-soluble guanidinylated chitosan: a candidate material for protein delivery systems. Polym J. 2023 May 10;55(8):885–95. doi: 10.1038/s41428-023-00787-4. 参考文献:10.1007/978-981-99-6940-1_3 摘要:Ravinayagam V, Jermy BR. Synthesis of Nanocarriers Loaded with Anti-Cancer Drugs by Using Functionalization or Conjugations, Encapsulation Methods. 2023. In: Nano Drug Delivery for Cancer Therapy. 参考文献:10.1007/s11172-024-4466-5 摘要:Olsufyeva EN, Shchekotikhin AE. Key areas of antibiotic research conducted at the Gause Institute of New Antibiotics. Russ Chem Bull. 2024 Dec;73(12):3523–66. doi: 10.1007/s11172-024-4466-5.